Thursday, September 11, 2014

Hospira Joins Business of Biosimilars, Last Chance to Save is This Friday

At this year's 15th Annual Business of Biosimilars Conference, partner with 100+ movers and shakers in the biosimilars space including pharma, biotech, and legal experts at the leading forum to drive commercialization and market access of biosimilar drugs. By attending, you will learn how to:
  • Identify business opportunities by analyzing the commercial realities of the market
  • Increase market access by expanding your global footprint in the US, EU, and emerging regions via a new "Around the World in One Day" workshop
  • Gain clarity from legal experts on state substitution laws, interchangeability, and takeways of high profile court cases
  • Navigate through regulatory complexities, maximize market uptake, and drive commercial success of a biosimilar drug
Plus! We're excited to announce that Mohamed H. Ladha, Global Biologics Marketing, Global Pharmaceutical Marketing, Hospira has joined the Biosimilars speaker faculty. Hear from him and other industry experts in the below panel:
Looking at the Commercial Realities of the Biosimilar Market
  • •  
    Moderator: John J. Lewis, Senior Vice President, Policy & Public Affairs,           Association of Clinical Research Organizations
  • •  
    • - Giles Somers, Lead Analyst, Generics and Biosimilars, Datamonitor
    • - Carsten Brockmeyer, CEO, Formycon AG
    • - Mohamed H. Ladha, Global Biologics Marketing, Global Pharmaceutical Marketing, Hospira
Don't miss out on the opportunity to gain a 360 degree view on regulatory complexities, policy adoption, globalization and commercialization of the biosimilars industry. Download the brochure today to see how you can capitalize on the expected growth in the biologic medicines market.

Don't forget! This Friday, 9/12 is your last chance to SAVE $200! PLUS, you can save an extra $100 as a reader of this blog for a total of $300.  Register here and use code XP1986BLOG.

Follow us on Twitter: @FutureOfBiopharma & @Biosimilars
Join us on LinkedIn

Share this article with your social network, just click below to share now!

No comments :

Post a Comment